Shanghai, China

Jianshu Xie



 

Average Co-Inventor Count = 6.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Jianshu Xie: Innovator in Pharmaceutical Chemistry

Introduction

Jianshu Xie is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of five patents to his name, Xie's work focuses on the development of novel compounds and their applications in medicine.

Latest Patents

Among his latest patents, Xie has developed salts of morpholine derivatives, which include various crystal forms and processes for their production. These novel pharmaceutically acceptable salts, such as malate, tartrate, hydrochloride, acetate, and naphthalene disulfonate, exhibit improved properties compared to known morpholine derivative free bases. The improvements include better crystalline states, enhanced water solubility, and increased light and thermal stability. Additionally, he has created a nitrogen-containing saturated heterocyclic compound that serves as a renin inhibitor, showcasing his expertise in medicinal chemistry.

Career Highlights

Jianshu Xie has worked with notable companies in the pharmaceutical industry, including Shanghai Pharmaceuticals Holding Co., Ltd. and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Xie has collaborated with esteemed colleagues such as Toru Iijima and Guangxin Xia. These partnerships have further enriched his research and innovation in the pharmaceutical field.

Conclusion

Jianshu Xie's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a leading inventor in the industry. His work continues to impact the development of new and effective pharmaceutical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…